Lentitek Secures £250k Seed Investment to Commercialize Biotechnologies Enabling Advanced Cancer Treatments and Gene Therapies

Latest Comments
No comments to show.

Originally posted on May 30, 2023 @ 11:15 Lentitek Ltd, an Edinburgh-based company specializing in the development of innovative manufacturing technologies for cost-effective delivery of advanced cell and gene therapies, has announced the successful raising of £250,000 ($300,000 USD) in seed investment. This funding will be utilized to advance its technology further and commence initial commercial…

Source

Categories

No responses yet

Leave a Reply

Your email address will not be published.